Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × PF-05280014 × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Triple Negative Breast Neoplasms 1 Rectal Neoplasms 1 Malignant Solid Neoplasm 1 Inflammatory Breast Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Bladder Urothelial Carcinoma 1 Advanced Breast Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Ipilimumab 96 pembrolizumab 81 Nivolumab 79 aldesleukin 51 Cyclophosphamide 49 Interleukin-2 38 fludarabine phosphate 31 Vemurafenib 31 Dacarbazine 31 dabrafenib 29 trametinib 28 Temozolomide 26 fludarabine 25 CTLA-4 Antigen 18 Bevacizumab 18 Radiosurgery 15 Paclitaxel 15 Carboplatin 14 encorafenib 13 binimetinib 13 Introns 13 talimogene laherparepvec 12 Interferon alpha-2 12 spartalizumab 10 cobimetinib 10 atezolizumab 10 Radiotherapy 10 sargramostim 9 peginterferon alfa-2b 9 montanide ISA 51 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡